Investigators earn Michael J. Fox Foundation award

Investigators at UF’s Center for Translational Research in Neurodegenerative Disease, or CTRND, earned a one-year, $200,000 award from the Michael J. Fox Foundation’s Target Advancement Program to explore novel approaches to treat Parkinson’s disease.

The award will fund a study to determine how targeting cannabinoid receptor 2, or CB2, could alter the behavior of microglia that interact with alpha-synuclein, a protein that aggregates in Parkinson’s disease.

Source link

Related posts

5 Scary Ways Alcohol Damages the Brain


Development of the Central Africa Daily Functioning Interference Scale for Dementia Diagnosis in Older Adults: The EPIDEMCA Study.


Cannabidiol Wins FDA Review for Tuberous Sclerosis Complex


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World